2015 | 1 | 55-59
Article title

Postępowanie w subklinicznej niedoczynności tarczycy u dorosłych

Title variants
Languages of publication
  • Kuliczkowska-Płaksej J, Tupikowska M, Zatońska K, i wsp. Subkliniczna dysfunkcja tarczycy – czy i kiedy leczyć? Fam Med Prim Care Rev 2013; 15(1): 27–33.
  • Pearce SHS, Brabant G, Duntas LH, et al. 2013 ET A Guidline: Management of subclinical hypothyroidism. Euro Thyr J 2013;2: 215–228.
  • Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow up of the Wickham Survey. Clin Endocrinol 1995; 43: 55–68.
  • Hollowell JG, Staehling NW , Flanders WD , et al. Serum TS H, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III ). J Clin Endocrinol Metab 2002; 87: 489–499.
  • Canaris GJ, Manowitz NR , Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160:526–534.
  • Garber JR , Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologist and the American Thyroid Association. Thyroid 2012; 22: 1200–1235.
  • Huber G, Staub JJ , Meier C, et al. Prospective study of the spontaneous course of subclinical hupothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab 2002; 87: 3221–3223.
  • Stanicka S, Vondra K, Pelikanova T, et al. Insulin sensitivity and counter-regulatory hormones in hypothyroidism and Turing thyroid hormone replacement therapy. Clin Chem Lab Med 2005; 43: 715–720.
  • Wartofsky L, Dickey RA. Controversy in clinical endocrinology. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metabol 2005; 90: 5483–5488.
  • Dayan CM, Saravanan P, Bayly G. Whose normal thyroid function is better – yours or mine? Lancet 2002; 360: 353–354.
  • Surks MI, Goswami G, Daniels GH. Controversy in clinical endocrinology. The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metabol 2005; 90: 5489–5496.
  • Razvi S, Ingoe L, Keeka G, et al. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism. J Clin Endocrinol Metab 2007; 92: 1715–1723.
  • Knudsen N, Laurberg P, Rasmussen LB, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005; 90: 4019–4024.
  • Gussekloo J, van Exel E, de Craen AJ, et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004; 292: 2591–2599
  • Bednarek-Tupikowska G, Adamarczuk-Janczyszyn M., Rakowska-Chort A, et al. Utajona niedoczynność tarczycy. Pol Arch Med Wewn 2006; 116: 974–979.
  • Taylor PN , Iqbal A, Minassian C, et al. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from large community-based study. JAMA Intern Med 2014; 174: 32–39.
  • Parle JV, Franklyn JA, Cross KW , et al. Thyroxine prescription in the community. Br J Gen Pract 1993; 43: 107–109.
  • Turner MR, Camacho X, Fischer HD, et al. Levothyroxine dose and risk of fractures in older adults. BMJ 2011; 342: d2238.
  • Flynn RW , Bonellie SR , Jung RT , et al. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab 2010; 95: 186–193.
  • Cooper DS , Biondi B. Subclinical thyroid disease. Lancet 2012; 379: 1142–1154.
  • Rozporządzenie Ministra Zdrowia z dnia 20.10.2014 r. zmieniające rozporządzenie w sprawie świadczeń gwarantowanych z zakresu podstawowej opieki zdrowotnej (Dz.U. z 2014 r., poz. 1440).
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.